Martingale Asset Management »

Fulcrum Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $97k 11k 9.20
2025-06-30 $626k 91k 6.88

More positions owned by Martingale Asset Management

Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Facebook Inc cl a (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Berkshire Hathaway (BRK.B)
At&t (T)
Exxon Mobil Corporation (XOM)
Visa (V)
Cisco Systems (CSCO)
MasterCard Incorporated (MA)
Wal-Mart Stores (WMT)
Verizon Communications (VZ)

View all positions for Martingale Asset Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics